J.B. Chemicals & Pharmaceuticals Lt (Delisted) MD, chairman, board of directors and AGM
BSE: 506943Pharmaceuticals & Biotechnology
Last traded ₹2,408.90 on 16 Jul 2026
Delisted on 12 Oct 2026.
J.B. Chemicals & Pharmaceuticals Lt board of directors
At the end of the quarter to Mar 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonArun Duggal
- Managing directorAman Mehta
- Company Secretary and Compliance OfficerSandeep Phadnis
8 directors4 independent1 executive3 non-executive
- Arun Duggal · ChairpersonIndependent · joined Jul 2024 · reappointed Jul 2024 · 20 months as independent · 2 listed boards · 2 as independent · 3 committee seats, 1 as chair
- Sumit BoseIndependent · joined Aug 2020 · reappointed Aug 2025 · 67 months as independent · 3 listed boards · 3 as independent · 6 committee seats, 3 as chair
- Ashwani Kumar PuriIndependent · joined May 2025 · reappointed May 2025 · 10 months as independent · 3 listed boards · 3 as independent · 6 committee seats, 4 as chair
- Richa AroraIndependent · joined Jul 2025 · reappointed Jul 2025 · 8 months as independent · 3 listed boards · 3 as independent · 4 committee seats, 1 as chair
- Aman Mehta · Managing directorExecutive · joined Jan 2026 · reappointed Jan 2026 · 3 listed boards · 1 committee seat
- Sudhir MenonNon-executive · joined Jan 2026 · reappointed Jan 2026 · 1 listed board · 2 committee seats
- Amal Satyawan KelshikarNon-executive · joined Jan 2026 · reappointed Jan 2026 · 1 listed board
- Hasmukh Mathurbhai PatelNon-executive · joined Jan 2026 · reappointed Jan 2026 · 1 listed board
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
5 directors who left
- Gaurav Trehan, left 21 Jan 2026: Others
- Prashant Kumar, left 21 Jan 2026: Others
- Akshay Tanna, left 21 Jan 2026: Others
- Nikhil Ashokkumar Chopra, left 21 Jan 2026: Others
- Padmini Khare Kaicker, left 30 Aug 2025: Tenure Completion
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 13 Mar 20267 of 8 present4 independent · 35 days in between
- 5 Feb 20268 of 8 present4 independent · 14 days in between
- 21 Jan 20268 of 8 present4 independent · 4 days in between
- 16 Jan 20268 of 8 present4 independent · 8 days in between
2 earlier meetings
- 7 Jan 20268 of 8 present4 independent · 56 days in between
- 11 Nov 20257 of 8 present4 independent
Audit Committee
Chair Ashwani Kumar Puri
Sumit Bose, Arun Duggal, Sudhir Menon
- 13 Mar 20263 of 4 present3 independent · 35 days in between
- 5 Feb 20264 of 4 present3 independent · 7 days in between
- 28 Jan 20264 of 4 present3 independent · 11 days in between
- 16 Jan 20264 of 4 present3 independent · 8 days in between
2 earlier meetings
- 7 Jan 20264 of 4 present3 independent · 56 days in between
- 11 Nov 20254 of 4 present3 independent
Nomination and remuneration committee
Chair Sumit Bose
Arun Duggal, Richa Arora
- 5 Feb 20264 of 4 present3 independent · 14 days in between
- 21 Jan 20263 of 3 present3 independent · 13 days in between
- 7 Jan 20264 of 4 present3 independent
Stakeholders Relationship Committee
Chair Sumit Bose
Ashwani Kumar Puri, Sudhir Menon
- 16 Jan 20263 of 3 present1 independent
Risk Management Committee
Chair Ashwani Kumar Puri
Sudhir Menon, Kaushal Singh Solanki
- 16 Jan 20263 of 3 present1 independent
Corporate Social Responsibility Committee
Chair Sumit Bose
Arun Duggal, Sudhir Menon
No meeting listed in the filing.
Compensation Committee
Chair Sumit Bose
Arun Duggal, Sudhir Menon, Prashant Kumar
- 21 Jan 20263 of 3 present2 independent · 13 days in between
- 7 Jan 20263 of 3 present2 independent
Share Transfer Committee
Chair Prashant Kumar
Richa Arora
No meeting listed in the filing.
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- Deloitte Haskins & Sells LLPPeer-review certificate valid to Jul 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
J.B. Chemicals & Pharmaceuticals Lt AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.J.B. Chemicals & Pharmaceuticals Lt dividend history
Annual general meeting, 17 Jun 2026
74,579 shareholders on the register on 10 Jun 2026; present: 1 promoter and 59 others; votes counted by Aishwarya Parekh / RPAP & Co..The company's voting result (opens in a new tab)
a) To receive, consider and adopt the Audited Financial Statements of the Company for the Financial Year ended on 31st March, 2026 together with the reports of the Board of Directors and the Auditors thereon, and b) To receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended on 31st March 31, 2026 together with the report of the Auditors thereonMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 83.46% · promoters 100.00% · institutions 90.44% · other public 5.69%
- To confirm the payment of interim dividend of Rs. 12.70 per equity share paid during the financial year 2025-26Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 83.48% · promoters 100.00% · institutions 90.48% · other public 5.69%
- To declare final dividend of Rs. 9.30 per equity share for the financial year 2025-26Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 83.48% · promoters 100.00% · institutions 90.48% · other public 5.69%
- To appoint a Director in place of Mr. Amal Kelshikar (holding DIN: 06378987), Director, who retires by rotation and being eligible, offers himself for re-appointmentOrdinary99.84% for0.16% against
Against: promoters 0.00% · institutions 0.39% · other public 0.36%
Turnout: all 83.46% · promoters 100.00% · institutions 90.44% · other public 5.69%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Meeting called by the tribunal, 28 Apr 2026, 1 resolution
73,425 shareholders on the register on 21 Apr 2026; present: 1 promoter and 48 others; votes counted by Rajesh Parekh / RPAP & Co..The company's voting result (opens in a new tab)
- To approve the proposed scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals LimitedSpecialPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 3.70%
Turnout: all 81.21% · promoters 100.00% · institutions 86.63% · other public 0.27%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 23 Mar 2026, 5 resolutions
70,715 shareholders on the register on 13 Feb 2026; votes counted by Ashish C Bhatt / Ashish Bhatt & Associates.The company's voting result (opens in a new tab)
- To appoint Mr. Aman Mehta (DIN: 08174906) as a Director of the Company.Ordinary99.26% for0.74% against
Against: promoters 0.00% · institutions 1.88% · other public 1.31%
Turnout: all 80.99% · promoters 100.00% · institutions 84.44% · other public 6.74%
- To appoint Mr. Aman Mehta (DIN: 08174906) as Managing Director.Ordinary99.85% for0.15% against
Against: promoters 0.00% · institutions 0.34% · other public 1.31%
Turnout: all 80.99% · promoters 100.00% · institutions 84.44% · other public 6.74%
- To appoint Mr. Amal Kelshikar (DIN: 06378987) as a Non-Executive, Non-Independent Director.Ordinary99.80% for0.20% against
Against: promoters 0.00% · institutions 0.48% · other public 1.31%
Turnout: all 80.99% · promoters 100.00% · institutions 84.44% · other public 6.74%
- To appoint Mr. Hasmukh Patel (DIN: 11486584) as a Non-Executive, Non-Independent Director.Ordinary99.80% for0.20% against
Against: promoters 0.00% · institutions 0.48% · other public 1.35%
Turnout: all 80.99% · promoters 100.00% · institutions 84.44% · other public 6.74%
- To appoint Mr. Sudhir Menon (DIN: 09502215) as a Non-Executive, Non-Independent Director.Ordinary99.81% for0.19% against
Against: promoters 0.00% · institutions 0.48% · other public 0.12%
Turnout: all 80.99% · promoters 100.00% · institutions 84.44% · other public 6.74%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 6 Aug 2025, 14 resolutions
73,904 shareholders on the register on 30 Jul 2025; present: 0 promoters and 54 others; votes counted by Ashish C. Bhatt / Ashish Bhatt & Associates.The company's voting result (opens in a new tab)
(a)Adoption of standalone audited financial statements for the year ended on March 31, 2025, and reports of Board of Directors and auditors’ thereon. (b) Adoption of consolidated audited financial statements for the year ended on March 31, 2025, and report of auditors’ thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 80.90% · promoters 100.00% · institutions 85.12% · other public 9.01%
- Confirmation of interim dividend of Rs. 8.50/- per equity share of face value Re. 1/- each, for the year ended on March 31, 2025.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 80.91% · promoters 100.00% · institutions 85.17% · other public 9.01%
- Declaration of final dividend of Rs. 7.00/- per equity share of face value Re. 1/- each, for the year ended on March 31, 2025.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 80.91% · promoters 100.00% · institutions 85.17% · other public 9.01%
- Re-appointment of Mr. Gaurav Trehan (DIN: 03467781) as a Director liable to retire by rotation.Ordinary76.99% for23.01% against
Against: promoters 0.00% · institutions 58.32% · other public 0.01%
Turnout: all 80.91% · promoters 100.00% · institutions 85.15% · other public 9.01%
- Re-appointment of Deloitte Haskins & Sells LLP, Chartered Accountants, as Statutory Auditors of the CompanyOrdinary89.65% for10.35% against
Against: promoters 0.00% · institutions 26.24% · other public 0.01%
Turnout: all 80.91% · promoters 100.00% · institutions 85.15% · other public 9.01%
- Appointment of Mr. Ashwani Kumar Puri (DIN: 00160662) as Non- Executive Independent Director of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 80.91% · promoters 100.00% · institutions 85.15% · other public 9.01%
- Reappointment of Mr. Sumit Bose (DIN: 03340616), as Non-Executive Independent Director of the CompanySpecial99.38% for0.62% against
Against: promoters 0.00% · institutions 1.56% · other public 0.04%
Turnout: all 80.91% · promoters 100.00% · institutions 85.15% · other public 9.01%
- Appointment of Ms. Richa Arora (DIN: 07144694) as Non-Executive Independent Director of the Company.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 80.91% · promoters 100.00% · institutions 85.15% · other public 9.01%
- Revision in remuneration of Mr. Nikhil Chopra (DIN: 07220097)- Chief Executive Officer and Whole-Time Director of the Company, for the period from April 1, 2025 to October 4, 2025.Ordinary89.92% for10.08% against
Against: promoters 0.00% · institutions 25.55% · other public 0.05%
Turnout: all 80.91% · promoters 100.00% · institutions 85.15% · other public 9.01%
- Reappointment of Mr. Nikhil Chopra (DIN: 07220097) as Chief Executive Officer and Whole-time Director of the CompanyOrdinary89.71% for10.29% against
Against: promoters 0.00% · institutions 26.10% · other public 0.01%
Turnout: all 80.85% · promoters 100.00% · institutions 84.99% · other public 9.01%
- Appointment of M/s. N L Bhatia & Associates, Practicing Company Secretary, as Secretarial Auditors of the CompanyOrdinary89.65% for10.35% against
Against: promoters 0.00% · institutions 26.24% · other public 0.01%
Turnout: all 80.91% · promoters 100.00% · institutions 85.15% · other public 9.01%
- Ratification of payment of remuneration of cost auditorOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 80.91% · promoters 100.00% · institutions 85.15% · other public 9.01%
- Change in registered office of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.10%
Turnout: all 80.91% · promoters 100.00% · institutions 85.15% · other public 9.01%
- Waiver of lock-in restrictions on transferability of the shares held by the Chief Executive Officer in case of a change in control under the ESOP SchemeSpecial99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 1.01%
Turnout: all 80.91% · promoters 100.00% · institutions 85.15% · other public 9.01%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 21 Aug 2024, 6 resolutions
Present: 0 promoters and 63 others.The company's voting result (opens in a new tab)
(a)Adoption of standalone audited financial statements for the year ended on March 31, 2024, and reports of Board of Directors and auditors’ thereon.n(b) Adoption of consolidated audited financial statements for the year ended on March 31, 2024, and report of auditors’ thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 80.81% · promoters 100.00% · institutions 85.30% · other public 8.33%
- Confirmation of interim dividend of Rs. 5.50/- per equity share of face value Re. 1/- each, for the year ended on March 31, 2024.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 80.83% · promoters 100.00% · institutions 85.38% · other public 8.33%
- Declaration of final dividend of Rs. 6.75/- per equity share of face value Re. 1/- each, for the year ended on March 31, 2024.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 80.83% · promoters 100.00% · institutions 85.38% · other public 8.33%
- Re-appointment of Mr. Prashant Kumar (DIN: 08342577) as a Director of the Company liable to retire by rotation.Ordinary98.47% for1.53% against
Against: promoters 0.00% · institutions 4.79% · other public 0.18%
Turnout: all 80.81% · promoters 100.00% · institutions 85.30% · other public 8.33%
- Approval of revision in remuneration of Mr. Nikhil Chopra (DIN: 07220097) Chief Executive Officer and Whole-Time Director of the Company, for the financial year 2024-25.Ordinary84.79% for15.21% against
Against: promoters 0.00% · institutions 47.81% · other public 0.18%
Turnout: all 80.81% · promoters 100.00% · institutions 85.30% · other public 8.33%
- Ratification of remuneration of cost auditor.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.18%
Turnout: all 80.81% · promoters 100.00% · institutions 85.30% · other public 8.33%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 5 Jul 2024, 1 resolution
The company's voting result (opens in a new tab)
- Appointment of Mr. Arun Duggal (DIN: 00024262) as a Non-Executive Independent Director of the CompanySpecial99.60% for0.40% against
Against: promoters 0.00% · institutions 1.30% · other public 0.23%
Turnout: all 80.05% · promoters 100.00% · institutions 82.88% · other public 9.83%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 7 Apr 2024, 1 resolution
The company's voting result (opens in a new tab)
- To approve appointment of Mr. Akshay Tanna (DIN: 02967021) as Non-Executive, Non-Independent Director of the Company.Ordinary92.89% for7.11% against
Against: promoters 0.00% · institutions 22.04% · other public 2.57%
Turnout: all 79.63% · promoters 100.00% · institutions 87.95% · other public 0.93%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 20 Dec 2023, 1 resolution
The company's voting result (opens in a new tab)
- To approve amendment to the Company's Employee Stock Option Scheme titled JBCPL Employee Stock Option Scheme 2021 ( Scheme or ESOP 2021 )Special85.24% for14.76% against
Against: promoters 0.00% · institutions 47.03% · other public 0.16%
Turnout: all 81.77% · promoters 100.00% · institutions 89.16% · other public 13.14%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.
Mutual fund votes, meeting of 17 Jun 2026, 35 fund houses
a) To receive, consider and adopt the Audited Financial Statements of the Company for the Financial Year ended on 31st March, 2026 together with the reports of the Board of Directors and the Auditors thereon, and b) To receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended on 31st March 31, 2026 together with the report of the Auditors thereonMoreLess
35 for0 against- To confirm the payment of interim dividend of Rs. 12.70 per equity share paid during the financial year 2025-2635 for0 against
- To declare final dividend of Rs. 9.30 per equity share for the financial year 2025-2635 for0 against
- To appoint a Director in place of Mr. Amal Kelshikar (holding DIN: 06378987), Director, who retires by rotation and being eligible, offers himself for re-appointment35 for0 against
Mutual fund votes, meeting of 28 Apr 2026, 34 fund houses
- To approve the proposed scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited34 for0 against
6 earlier meetings
Mutual fund votes, meeting of 23 Mar 2026, 30 fund houses
- To appoint Mr. Aman Mehta (DIN: 08174906) as a Director of the Company.30 for0 against
- To appoint Mr. Aman Mehta (DIN: 08174906) as Managing Director.30 for0 against
- To appoint Mr. Amal Kelshikar (DIN: 06378987) as a Non-Executive, Non-Independent Director.30 for0 against
- To appoint Mr. Hasmukh Patel (DIN: 11486584) as a Non-Executive, Non-Independent Director.30 for0 against
- To appoint Mr. Sudhir Menon (DIN: 09502215) as a Non-Executive, Non-Independent Director.30 for0 against
Mutual fund votes, meeting of 6 Aug 2025, 26 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
(a)Adoption of standalone audited financial statements for the year ended on March 31, 2025, and reports of Board of Directors and auditors’ thereon. (b) Adoption of consolidated audited financial statements for the year ended on March 31, 2025, and report of auditors’ thereon.MoreLess
26 for0 against- Confirmation of interim dividend of Rs. 8.50/- per equity share of face value Re. 1/- each, for the year ended on March 31, 2025.26 for0 against
- Declaration of final dividend of Rs. 7.00/- per equity share of face value Re. 1/- each, for the year ended on March 31, 2025.26 for0 against
- Re-appointment of Mr. Gaurav Trehan (DIN: 03467781) as a Director liable to retire by rotation.
Against Axis Mutual Fund, Franklin Templeton Mutual Fund, HSBC Mutual Fund, Invesco Mutual Fund, Sundaram Mutual Fund
- Axis Mutual Fund, Sundaram Mutual FundGaurav Trehan, 48, is Partner, Co-Head of KKR Asia Pacific, Head of the Asia – Pacific Private Equity business and Chief Executive Officer for KKR India. He represents Tau Investment Holdings Pte. Ltd. (KKR), the promoter on the board. He retires by rotation. Gaurav Trehan attended 63% (five out of eight) board meetings in FY25 and 65% (15 out of 23) board meetings over the last three years: we have a threshold of 75% attendance of the board meetings in the three years prior to re-appointment. Given the low board meeting attendance, we are unable to support his reappointment on the board.
- Franklin Templeton Mutual FundA vote AGAINST the following nominee is warranted because Gaurav Trehan has failed to attend at least 75 percent of board meetings in the most recent fiscal year, without a satisfactory explanation.
- HSBC Mutual FundA vote FOR all the nominees is warranted given the absence of any known issues concerning the nominees and the company's board and committee dynamics.
- Invesco Mutual FundGaurav Trehan, 48, is Partner, Co-Head of KKR Asia Pacific, Head of the Asia – Pacific Private Equity business and Chief Executive Officer for KKR India. He represents Tau Investment Holdings Pte. Ltd. (KKR), the promoter on the board. He retires by rotation. Gaurav Trehan attended 63% (five out of eight) board meetings in FY25 and 65% (15 out of 23) board meetings over the last three years: we have a threshold of 75% attendance of the board meetings in the three years prior to re-appointment. Given the low board meeting attendance, we are unable to support his reappointment on the board. We do not support the resolution.
21 for5 against - Re-appointment of Deloitte Haskins & Sells LLP, Chartered Accountants, as Statutory Auditors of the Company
Against Angel One Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Helios Mutual Fund, Kotak Mahindra Mutual Fund, LIC Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual Fund
- Angel One Mutual FundProposed audit fee payable to Statutory Auditors not disclosed.
- Edelweiss Mutual Fund, Groww Mutual Fund, Helios Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, PGIM India Mutual FundNo issues on merits of the proposed Statutory Auditors. Non-Compliant with Regulation 36(5) of SEBI LODR: Proposed audit fee payable to Statutory Auditors not disclosed.
- Kotak Mahindra Mutual FundDeloitte Haskins & Sells LLP were appointed as statutory auditors of the Company for five years from 23 December 2020 until the 2025 AGM. The company now proposes to reappoint them as statutory auditors for a second term of five years from the conclusion of the 2025 AGM till the conclusion of the 2030 AGM. The company has not disclosed the proposed auditor remuneration to shareholders, which is a regulatory requirement. Hence, we are voting against.
- LIC Mutual FundConcerns over Proposed audit fee payable to Statutory Auditors not disclosed.
- Nippon India Mutual FundNon disclosure of Proposed fee payable to Statuatory Auditors.
16 for10 against - Appointment of Mr. Ashwani Kumar Puri (DIN: 00160662) as Non- Executive Independent Director of the Company26 for0 against
- Reappointment of Mr. Sumit Bose (DIN: 03340616), as Non-Executive Independent Director of the Company26 for0 against
- Appointment of Ms. Richa Arora (DIN: 07144694) as Non-Executive Independent Director of the Company.26 for0 against
- Revision in remuneration of Mr. Nikhil Chopra (DIN: 07220097)- Chief Executive Officer and Whole-Time Director of the Company, for the period from April 1, 2025 to October 4, 2025.
Against Angel One Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Helios Mutual Fund, HSBC Mutual Fund, LIC Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, PGIM India Mutual Fund
- Angel One Mutual Fund, LIC Mutual FundGovernance concern: Excessive perquisite value as per Granted Options.
- Edelweiss Mutual Fund, Groww Mutual Fund, Helios Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, PGIM India Mutual FundCompliant with law. Governance concern: Excessive perquisite value as per Granted Options.
- HSBC Mutual FundA vote AGAINST these resolutions is warranted in view of the following concerns in the executive'sremuneration:• He has been granted stock options, which are subject to vesting upon specified performance conditions,and he is entitled to variable pay components. The circular lacks disclosure on the specific performance metrics, threshold and target levels, that determine the vesting of options and the payouts under the variable pay element.• His remuneration (including stock options) in the past three years is deemed to be high.• The estimated remuneration of the executive is aggressively positioned against that of industry peers.
17 for9 against - Reappointment of Mr. Nikhil Chopra (DIN: 07220097) as Chief Executive Officer and Whole-time Director of the Company
Against Angel One Mutual Fund, Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Helios Mutual Fund, HSBC Mutual Fund, Invesco Mutual Fund, LIC Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, PGIM India Mutual Fund
- Angel One Mutual Fund, LIC Mutual FundGovernance concern: Excessive perquisite value as per Granted Options.
- Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Helios Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, PGIM India Mutual FundCompliant with law. Governance concern: Excessive perquisite value as per Granted Options.
- HSBC Mutual FundA vote AGAINST these resolutions is warranted in view of the following concerns in the executive'sremuneration:• He has been granted stock options, which are subject to vesting upon specified performance conditions,and he is entitled to variable pay components. The circular lacks disclosure on the specific performance metrics, threshold and target levels, that determine the vesting of options and the payouts under the variable pay element.• His remuneration (including stock options) in the past three years is deemed to be high.• The estimated remuneration of the executive is aggressively positioned against that of industry peers.
- Invesco Mutual FundNikhil Chopra received Rs. 303.9 mn as remuneration in FY25 (including fair value of stock options granted in FY22). The cash component (fixed plus variable) of the proposed remuneration terms is capped at Rs. 100.0 mn per annum, of which 37% will be variable pay: this relatively low variable component offers limited alignment between executive compensation and company performance. The resolution does not address Nikhil Chopra’s eligibility for any additional stock option grants; the last award of 1.8 million options was made in FY22, with the final tranche expected to have vested on 1 April 2025. The board must confirm that the company will seek separate shareholder approval for any incremental stock options to be granted to Nikhil Chopra during the proposed term. In the absence of clarity with respect to stock option grants, we are unable to estimate the proposed compensation. Therefore, although we support Nikhil Chopra’s reappointment, we do not support the proposed remuneration. We do not support the resolution.
15 for11 against - Appointment of M/s. N L Bhatia & Associates, Practicing Company Secretary, as Secretarial Auditors of the Company
Against Angel One Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Helios Mutual Fund, Kotak Mahindra Mutual Fund, LIC Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual Fund
- Angel One Mutual FundProposed fee payable to Secretarial Auditors not disclosed. Transparency Concern: Remuneration of outgoing auditor not disclosed, thus, material change, if any, with proposed audit fee cannot be ascertained.
- Edelweiss Mutual Fund, Groww Mutual Fund, Helios Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, PGIM India Mutual FundNo concern on merit of the proposed Secretarial Auditors. Non-Compliant with Regulation 36(5) of SEBI LODR: Proposed fee payable to Secretarial Auditors not disclosed. Transparency Concern: Remuneration of outgoing auditor not disclosed, thus, material change, if any, with proposed audit fee cannot be ascertained.
- Kotak Mahindra Mutual FundThe company proposes to appoint N L Bhatia & Associates as secretarial auditors for five years from 1 April 2025 to 31 March 2030. As per regulatory requirements, the company has not disclosed the proposed remuneration to the secretarial auditors. Hence, we do not support the resolution and voting against.
- LIC Mutual FundConcerns over Proposed fee payable to Secretarial Auditors not disclosed. Transparency Concern: Remuneration of outgoing auditor not disclosed, thus, material change, if any, with proposed audit fee cannot be ascertained.
- Nippon India Mutual FundNon disclosure of Proposed fee payable to Secretarial Auditors.
16 for10 against - Ratification of payment of remuneration of cost auditor26 for0 against
- Change in registered office of the Company25 for0 against
- Waiver of lock-in restrictions on transferability of the shares held by the Chief Executive Officer in case of a change in control under the ESOP Scheme26 for0 against
1 proposal not matched to one resolution
To shift the existing registered office of the Company from Neelam Centre, B Wing, 4th Floor, Hind Cycle Road, Worli, Mumbai 400030 falling within the jurisdiction of the Registrar of the Companies, Mumbai (Registered Office) to 302, Iscon Mall, Star India Bazar Building, Opp. Jodhpur BRTS satellite, Ahmedabad - 380 015, falling within the jurisdiction of the Registrar of Companies, Ahmedabad or such other place as may be determined by the Board of Directors of the Company in the State of Gujarat from time to time, subject to Torrent Pharmaceuticals Limited receiving approval from the Competition Commission of India in relation to the proposed amalgamation of the Company with Torrent Pharmaceuticals Limited.MoreLess
1 for0 against
Mutual fund votes, meeting of 21 Aug 2024, 24 fund houses
(a)Adoption of standalone audited financial statements for the year ended on March 31, 2024, and reports of Board of Directors and auditors’ thereon.n(b) Adoption of consolidated audited financial statements for the year ended on March 31, 2024, and report of auditors’ thereon.MoreLess
24 for0 against- Confirmation of interim dividend of Rs. 5.50/- per equity share of face value Re. 1/- each, for the year ended on March 31, 2024.24 for0 against
- Declaration of final dividend of Rs. 6.75/- per equity share of face value Re. 1/- each, for the year ended on March 31, 2024.24 for0 against
- Re-appointment of Mr. Prashant Kumar (DIN: 08342577) as a Director of the Company liable to retire by rotation.24 for0 against
- Approval of revision in remuneration of Mr. Nikhil Chopra (DIN: 07220097) Chief Executive Officer and Whole-Time Director of the Company, for the financial year 2024-25.
Against Axis Mutual Fund, Bandhan Mutual Fund, Bank of India Mutual Fund, DSP Mutual Fund, Franklin Templeton Mutual Fund, Groww Mutual Fund, HSBC Mutual Fund, Invesco Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, NJ Mutual Fund, Sundaram Mutual Fund
- Axis Mutual Fund, Bank of India Mutual Fund, DSP Mutual Fund, Sundaram Mutual FundNikhil Chopra Chief Executive Officer (CEO) has been on the board since October 2020. We estimate Nikhil Chopra’s FY25 remuneration at Rs. 304.9 mn. The proposed remuneration is higher than peers and high compared to the size of the company (~4.1% of FY24 PBT). The performance-based criteria disclosed in the original agreement does not form part of the amended agreement. Therefore, there is no clarity on the performance metrics that will determine his short and long-term variable pay. Also, stock options granted to Nikhil Chopra in FY22 in excess of 1% of paid-up share capital under the company’s 2021 ESOP plan can result in his remuneration exceeding 5% of profits in any given year during his current tenure
- Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual FundCompliant with law. Governance concern: Excessive perquisite value as per Granted Options.
- Franklin Templeton Mutual Fund, HSBC Mutual FundA vote AGAINST this resolution is warranted in view of the following concerns in the executive's remuneration: • The overall remuneration including stock options is deemed to be significantly higher than industry standards and market peers of commensurate scale and operations. • There is no disclosure provided by the company on the amount of stock options to be granted to the executive and the price at which such options would be granted. • His remuneration (including stock options) in the past three years is deemed to be high. • The performance metrics, targets and thresholds for determining variable pay have not been disclosed.
- Invesco Mutual FundNikhil Chopra Chief Executive Officer (CEO) has been on the board since October 2020. We estimate Nikhil Chopra’s FY25 remuneration at Rs. 304.9 mn. The proposed remuneration is higher than peers and high compared to the size of the company (~4.1% of FY24 PBT). The performance-based criteria disclosed in the original agreement does not form part of the amended agreement. Therefore, there is no clarity on the performance metrics that will determine his short and long-term variable pay. Also, stock options granted to Nikhil Chopra in FY22 in excess of 1% of paid-up share capital under the company’s 2021 ESOP plan can result in his remuneration exceeding 5% of profits in any given year during his current tenure This is in line with our ESG framework
- NJ Mutual FundNikhil Chopra Chief Executive Officer (CEO) has been on the board since October 2020. We estimate Nikhil Chopra’s FY25 remuneration at Rs. 304.9 mn. The proposed remuneration is higher than peers and high compared to the size of the company (~4.1% of FY24 PBT). The performance-based criteria disclosed in the original agreement does not form part of the amended agreement. Therefore, there is no clarity on the performance metrics that will determine his short and long-term variable pay. Also, stock options granted to Nikhil Chopra in FY22 in excess of 1% of paid-up share capital under the company’s 2021 ESOP plan can result in his remuneration exceeding 5% of profits in any given year during his current tenure.
12 for12 against - Ratification of remuneration of cost auditor.24 for0 against
Mutual fund votes, meeting of 5 Jul 2024, 25 fund houses
- Appointment of Mr. Arun Duggal (DIN: 00024262) as a Non-Executive Independent Director of the Company25 for0 against
Mutual fund votes, meeting of 7 May 2024, 1 fund house
- To appoint Mr. Arun Duggal (DIN: 00024262) as a Non-Executive Independent Director of the Company.1 for0 against
Mutual fund votes, meeting of 7 Apr 2024, 26 fund houses
- To approve appointment of Mr. Akshay Tanna (DIN: 02967021) as Non-Executive, Non-Independent Director of the Company.
Against Bandhan Mutual Fund, Groww Mutual Fund, Kotak Mahindra Mutual Fund, Mahindra Manulife Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual Fund
- Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, PGIM India Mutual FundNo concern identified w.r.t. the merits of the proposed appointee. Non-Compliant with SEBI LODR Regulations: Delayed approval of shareholders.
- Kotak Mahindra Mutual FundNo concern has been identified with the profile, time commitments and attendance of Mr. Akshay Tanna . However, the Board has already appointed him as a Non-Executive Non Independent Director of the Company w.e.f. 7th November 2023. The approval of the same is being passed in the respective resolution. Therefore, more than three months have already passed before the approval for his appointment. This defies the Regulation 17(1C) of the SEBI LODR Regulations. The resolution is non-compliant by the law and doesn t adhere to the provisions of Companies Act, 2013. Hence voting against.
- Mahindra Manulife Mutual FundNo concern identified w.r.t. the merits of the proposed appointee. Non-Compliant with SEBI LODR Regulations: Delayed approval of shareholders. The Company could have taken approval for his appointment as NED on the Board in its Postal Ballot dtd. 20th December, 2023.
- Nippon India Mutual FundDelayed Shareholder approval
19 for7 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Fines
Reported in the filing for the quarter to Mar 2026.
- Fine or penaltyAdditional Commissioner Grade II Appeal, LucknowSince 28 Mar 2026
Order passed under rule 113 of CGST Rules,2017 in Form APL-04 imposing penalty of Rs 3,94,981/-
The demand is raised in respect of alleged excess availment of ITC for the financial year 2020-21
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- Yes
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- Yes
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.